Standards Comparison

    ISO 13485

    Mandatory
    2016

    International standard for medical device quality management systems

    VS

    EU AI Act

    Mandatory
    2024

    EU regulation for risk-based AI safety and governance

    Quick Verdict

    ISO 13485 provides QMS certification for medical devices globally, enabling market access and risk control. EU AI Act mandates risk-based compliance for AI systems in EU, prohibiting harms and requiring conformity assessments to ensure safety.

    Quality Management

    ISO 13485

    ISO 13485:2016 Medical devices Quality management systems

    Cost
    €€€€
    Complexity
    High
    Implementation Time
    12-18 months

    Key Features

    • Risk-based controls for device safety and compliance
    • Full medical device lifecycle coverage
    • Mandatory medical device files for traceability
    • Process and software validation requirements
    • Post-market surveillance and complaint handling
    Artificial Intelligence

    EU AI Act

    Regulation (EU) 2024/1689 Artificial Intelligence Act

    Cost
    €€€
    Complexity
    Medium
    Implementation Time
    18-24 months

    Key Features

    • Risk-based four-tier AI classification framework
    • Prohibitions on unacceptable-risk AI practices
    • High-risk conformity assessment and CE marking
    • GPAI model systemic risk obligations
    • Lifecycle post-market monitoring and fines

    Detailed Analysis

    A comprehensive look at the specific requirements, scope, and impact of each standard.

    ISO 13485 Details

    What It Is

    ISO 13485:2016 is an international certification standard titled Medical devices — Quality management systems — Requirements for regulatory purposes. It provides a risk-based framework for organizations to demonstrate consistent provision of safe medical devices across the lifecycle, from design to disposal, integrating customer and regulatory requirements.

    Key Components

    • Organized into Clauses 4–8: QMS/documentation, management responsibility, resources, product realization, measurement/improvement.
    • Emphasizes documented procedures, medical device files, process validation, traceability, and post-market surveillance.
    • Built on process approach with ISO 9001 compatibility but enhanced for regulatory needs.
    • Third-party certification via accredited bodies with stage audits and surveillance.

    Why Organizations Use It

    • Enables market access (EU MDR, FDA QMSR alignment by 2026).
    • Mitigates risks of recalls, liabilities via robust controls.
    • Builds stakeholder trust, supplier partnerships, operational efficiency.
    • Strategic for scaling, international expansion, regulatory convergence.

    Implementation Overview

    • Phased: gap analysis, process design, validation, audits (9–18 months typical).
    • Applies to manufacturers, suppliers, distributors globally.
    • Requires eQMS, training, CAPA; certification every 3 years.

    EU AI Act Details

    What It Is

    The EU Artificial Intelligence Act (Regulation (EU) 2024/1689) is a comprehensive EU regulation and the world's first horizontal AI framework. It ensures safe, transparent AI respecting fundamental rights across sectors. Employing a risk-based approach, it tiers systems as unacceptable (prohibited), high-risk, limited-risk (transparency), or minimal-risk.

    Key Components

    • Prohibitions (Art. 5), high-risk obligations (Arts. 9-15: risk management, data governance, documentation, oversight, cybersecurity), GPAI rules (Chapter V)
    • Lifecycle controls via conformity assessment, CE marking, EU registration
    • Aligned with GDPR, product safety laws; presumption via harmonized standards
    • Enforced by AI Office, national authorities with fines to 7% global turnover

    Why Organizations Use It

    • Mandatory EU market access, avoiding severe penalties
    • Mitigates safety, rights risks; builds deployer/provider accountability
    • Enhances trust, competitiveness in regulated sectors like HR, biometrics
    • Enables innovation sandboxes, global compliance leadership

    Implementation Overview

    • Phased (6-36 months): inventory, classify, build QMS/RMS, conformity
    • Cross-functional governance, documentation-heavy; audits/notified bodies
    • Applies to providers/deployers in EU scope, all sizes/industries

    Key Differences

    Scope

    ISO 13485
    Medical device QMS lifecycle
    EU AI Act
    Risk-based AI systems lifecycle

    Industry

    ISO 13485
    Medical devices globally
    EU AI Act
    All sectors in EU

    Nature

    ISO 13485
    Voluntary certification standard
    EU AI Act
    Mandatory EU regulation

    Testing

    ISO 13485
    Process validation, audits
    EU AI Act
    Conformity assessment, notified bodies

    Penalties

    ISO 13485
    Loss of certification
    EU AI Act
    Up to 7% global turnover fines

    Frequently Asked Questions

    Common questions about ISO 13485 and EU AI Act

    ISO 13485 FAQ

    EU AI Act FAQ

    You Might also be Interested in These Articles...

    Run Maturity Assessments with GRADUM

    Transform your compliance journey with our AI-powered assessment platform

    Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

    100+ Standards & Regulations
    AI-Powered Insights
    Collaborative Assessments
    Actionable Recommendations

    Check out these other Gradum.io Standards Comparison Pages